<DOC>
	<DOCNO>NCT00032773</DOCNO>
	<brief_summary>To determine safe effective dose pentostatin steroid-refractory aGvHD identify minimal effective dose pentostatin define low dose produce response 20 % patient produce treatment failure ( defines death , grade 3/4 toxicity , progressive disease ) 40 % less patient .</brief_summary>
	<brief_title>Dose-finding Study Using Pentostatin Injection Treatment Steroid-refractory aGvHD</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Pentostatin</mesh_term>
	<criteria>Inclusion : Patients 6 month age grade 2 GVHD steroidrefractory Must engraft ANC 1000/mL , may still transfusion dependent platelet PRBC Time post stem cell infusion &lt; 100 day Written informed consent Must adequate renal function ( creatinine clearance 40 mL/min/1.73 m2 Exclusion : Posttransplant lymphoproliferative disease Uncontrolled infection Mental illness condition prevent full cooperation treatment monitoring requirement study ATG within previous 14 day Other immunosuppressive agent ( include monoclonal antibody ) initiate within previous 7 day .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>acute graft versus host disease</keyword>
	<keyword>aGVHD</keyword>
	<keyword>allogeneic hematopoietic stem cell transplantation</keyword>
	<keyword>peripheral blood stem cell transplantation</keyword>
	<keyword>cord blood transplant</keyword>
	<keyword>pentostatin</keyword>
	<keyword>Nipent</keyword>
	<keyword>deoxycoformycin</keyword>
</DOC>